ETIDRONATE DISODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Etidronate Disodium, and when can generic versions of Etidronate Disodium launch?
Etidronate Disodium is a drug marketed by Mylan and is included in one NDA.
The generic ingredient in ETIDRONATE DISODIUM is etidronate disodium. There are four drug master file entries for this compound. Additional details are available on the etidronate disodium profile page.
Summary for ETIDRONATE DISODIUM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 62 |
Clinical Trials: | 1 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ETIDRONATE DISODIUM |
DailyMed Link: | ETIDRONATE DISODIUM at DailyMed |
Recent Clinical Trials for ETIDRONATE DISODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
UMC Utrecht | Phase 2 |
Netherlands Brain Foundation | Phase 2 |
US Patents and Regulatory Information for ETIDRONATE DISODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan | ETIDRONATE DISODIUM | etidronate disodium | TABLET;ORAL | 075800-001 | Jan 24, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan | ETIDRONATE DISODIUM | etidronate disodium | TABLET;ORAL | 075800-002 | Jan 24, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |